SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001193125-24-094754
Filing Date
2024-04-12
Accepted
2024-04-12 16:30:30
Documents
11
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 PRE 14A d781963dpre14a.htm PRE 14A 372789
2 GRAPHIC g781963dps43g.jpg GRAPHIC 3823
3 GRAPHIC g781963dsp43b.jpg GRAPHIC 97501
4 GRAPHIC g781963dsp43c.jpg GRAPHIC 27430
5 GRAPHIC g781963dsp43d.jpg GRAPHIC 3792
6 GRAPHIC g781963dsp43e.jpg GRAPHIC 3294
7 GRAPHIC g781963dsp43f.jpg GRAPHIC 3320
8 GRAPHIC g781963dsp44.jpg GRAPHIC 11650
9 GRAPHIC g781963dsp44a.jpg GRAPHIC 1259
10 GRAPHIC g781963dsp44b.jpg GRAPHIC 1423
11 GRAPHIC g781963g03v00.jpg GRAPHIC 58328
  Complete submission text file 0001193125-24-094754.txt   662570
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39334 | Film No.: 24841883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)